CNS/Brain Cancer
From the Journals
Cancer pain declines with cannabis use
Lower use of other meds was also seen in patients who used cannabis.
Conference Coverage
Study gives new insight into timing of combo treatment in metastatic NSCLC
Best outcomes came when immunotherapy followed radiotherapy by 1-12 months.
Conference Coverage
First target doesn’t affect survival in NSCLC with brain metastases
Patient outcomes didn’t hinge on whether oncologists treated the brain or lung first.
Latest News
People with cancer should be wary of taking dietary supplements
Many patients still think over-the-counter vitamins, minerals, or herbal remedies will help.
Latest News
Small study finds high dose vitamin D relieved toxic erythema of chemotherapy
Five of the six patients had a hematologic condition that required induction chemotherapy before hematopoietic stem cell transplant.
Latest News
A single pediatric CT scan raises brain cancer risk
"CT examinations should only be used when necessary, and if they are used, the lowest achievable dose should be applied."
Perspectives
Diagnosed too late
We take a course in giving bad news, but every doctor has his or her own approach.
Commentary
Discontinuing immunotherapy: Is the infusion bag half empty or half full?
Clinical trials of immunotherapy or chemoimmunotherapy have generally terminated treatment in nonprogressing patients after 2 years.
Conference Coverage
A farewell to arms? Drug approvals based on single-arm trials can be flawed
Objective responses, not time-dependent survival outcomes, should be endpoints for single-arm trials, with results only used for conditional...
Conference Coverage
Time to cancer diagnoses in U.S. averages 5 months
Diagnosis time varied significantly across tumor types, as well as within the same tumor type.
Feature
Getting cancer research on track again may require a ‘behemoth’ effort
Cancer Moonshot aims to cut cancer-related deaths in half, but funding and pandemic challenges may hinder progress.